Originally posted by: 911paramedic
Originally posted by: richardycc
because it is more profitable to treat the disease than to cure or prevent it.
QFT
Sad, but true.
Yeah because there are so many treatments for crohns.....
:roll:
Originally posted by: 911paramedic
Originally posted by: richardycc
because it is more profitable to treat the disease than to cure or prevent it.
QFT
Sad, but true.
Originally posted by: Codewiz
Originally posted by: 911paramedic
Originally posted by: richardycc
because it is more profitable to treat the disease than to cure or prevent it.
QFT
Sad, but true.
Yeah because there are so many treatments for crohns.....
:roll:
Originally posted by: jpeyton
One cheap vaccine, or a lifetime worth of Crohn's medication...which one would pharmaceutical companies rather sell?
The research has been highly researched properly by one man! A specialist whom should have retired years ago but carried on to prove his 'theory' and get rid of this horrid disease. And he recieves no support from the medical community OR from any charities. Why?... because the vaccine will destroy drug companies profits on IBD drugs and the charities supposedly supporting people with crohn's will be out of a business & thus everyone employed by them out of a job (they don't work for free). His funding comes from private people whom have family members with IBD, so yes he needs your support to complete the vaccine trials both in terms of financial support but also in spreading the word aobut it.
The Prof's research is sound. Watch any of the youtube clips of his lectures about MAP. To understand the vaccine you have to understand the cause which he clearly explains and it is common sense once you realise.
Although there was a short-term benefit of the antibiotics at 16 weeks additional to the effect of corticosteroid therapy, the study showed no prolonged advantage of the antibiotic combination either during the 2-year treatment phase or, importantly, after therapy was stopped.
In view of recent genomic findings that implicate altered innate immune responses to intracellular bacteria in the aetiopathogenesis of Crohn's disease,4 the effect seen in this trial may be telling, and suggests the value of further studies, both fundamental and clinical, on the role of mycobateria in Crohn's disease.